SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $40.59 | 52-week high | $44.84 |
| Prev. close | $40.44 | 52-week low | $38.18 |
| Day low | $40.41 | Volume | 8,432 |
| Day high | $40.61 | Avg. volume | 55,512 |
| 50-day MA | $41.27 | Dividend yield | 1.53% |
| 200-day MA | $41.77 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 232.38M |
| Net Asset Value (NAV) | $40.41 |
| Options? | Yes |
| Total Holdings | 42 |
XPH Top Holdings
| Symbol | Company | % of Total |
| LLY | ELI LILLY + CO | 6.14% |
| AXSM | AXSOME THERAPEUTICS INC | 5.52% |
| MRK | MERCK + CO. INC. | 4.56% |
| ZTS | ZOETIS INC | 4.55% |
| JNJ | JOHNSON + JOHNSON | 4.52% |
| RPRX | ROYALTY PHARMA PLC CL A | 4.44% |
| BMY | BRISTOL MYERS SQUIBB CO | 4.36% |
| ITCI | INTRA CELLULAR THERAPIES INC | 4.32% |
| PFE | PFIZER INC | 4.28% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 4.27% |
XPH Price Returns
| 1-mo | -4.38% |
| 3-mo | -2.36% |
| 6-mo | -3.48% |
| 1-year | -2.23% |
| 3-year | -3.14% |
| 5-year | -1.73% |
| YTD | -0.60% |
| 2022 | -9.83% |
| 2021 | -10.54% |
| 2020 | 14.68% |
| 2019 | 25.61% |
| 2018 | -15.32% |
XPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||